These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. The evolving options in metastatic castration-sensitive prostate cancer. Hamilou Z Curr Opin Support Palliat Care; 2020 Sep; 14(3):270-275. PubMed ID: 32701855 [TBL] [Abstract][Full Text] [Related]
55. Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Smith MR; Saad F; Rathkopf DE; Mulders PFA; de Bono JS; Small EJ; Shore ND; Fizazi K; Kheoh T; Li J; De Porre P; Todd MB; Yu MK; Ryan CJ Eur Urol; 2017 Jul; 72(1):10-13. PubMed ID: 28314611 [TBL] [Abstract][Full Text] [Related]
57. The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer. van Soest RJ; Nieuweboer AJ; de Morrée ES; Chitu D; Bergman AM; Goey SH; Bos MM; van der Meer N; Hamberg P; de Wit R; Mathijssen RH; Eur J Cancer; 2015 Nov; 51(17):2562-9. PubMed ID: 26278646 [TBL] [Abstract][Full Text] [Related]
58. Navigating systemic therapy for metastatic castration-naïve prostate cancer. Kwan EM; Thangasamy IA; Teh J; Alghazo O; Sathianathen NJ; Lawrentschuk N; Azad AA World J Urol; 2021 Feb; 39(2):339-348. PubMed ID: 31897602 [TBL] [Abstract][Full Text] [Related]
59. Castration-resistant prostate cancer: from new pathophysiology to new treatment. Sridhar SS; Freedland SJ; Gleave ME; Higano C; Mulders P; Parker C; Sartor O; Saad F Eur Urol; 2014 Feb; 65(2):289-99. PubMed ID: 23957948 [TBL] [Abstract][Full Text] [Related]
60. Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations. Karzai F; VanderWeele D; Madan RA; Owens H; Cordes LM; Hankin A; Couvillon A; Nichols E; Bilusic M; Beshiri ML; Kelly K; Krishnasamy V; Lee S; Lee MJ; Yuno A; Trepel JB; Merino MJ; Dittamore R; Marté J; Donahue RN; Schlom J; Killian KJ; Meltzer PS; Steinberg SM; Gulley JL; Lee JM; Dahut WL J Immunother Cancer; 2018 Dec; 6(1):141. PubMed ID: 30514390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]